Lymphoma Research Foundation to Fund Research in Three Disease Subtypes

Share Article

Foundation to Award Grants for Promising Research in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Follicular Lymphoma and Mantle Cell Lymphoma

News Image

The Lymphoma Research Foundation (LRF) – the nation’s largest nonprofit devoted to funding innovative lymphoma research – is currently seeking proposals for high quality research studies in three key disease areas, namely chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), follicular lymphoma (FL), and mantle cell lymphoma (MCL). These grants will provide upwards of $2 million to support projects aimed at gaining a better understanding of these particular subtypes of lymphoma, as well as for the disease in general.

Each grant will be two to three years in duration with a total value of $250,000 to $450,000 per award. The funding for each award will support studies in the diagnosis and treatment of lymphoma, including priority areas such as understanding the biology of the disease, novel therapies, and drug resistance.

“These proposals emphasize the Lymphoma Research Foundation’s commitment to funding innovative research that will improve treatments for those living with lymphoma and ultimately discover a cure for this type of blood cancer,” said Diane Blum, LRF Chief Executive Officer. “The Foundation is grateful to its supporters, whose generosity enables LRF to expand its research portfolio and continue its work toward eradicating lymphoma.”

The Foundation’s Scientific Advisory Board, which is comprised of 45 world renowned experts in the field of lymphoma, will review the proposals and then select the top ranking grants for funding in each of the disease-specific focus areas.

“The Foundation’s disease-specific research initiatives deepen our insights into particular forms of lymphoma, while also delivering advances that are relevant to the spectrum of lymphomas more generally,” said Dr. John P. Leonard, Chair of LRF’s Scientific Advisory Board, the Richard T. Silver Distinguished Professor of Hematology and Medical Oncology and Associate Dean for Clinical Research at Weill Cornell Medical College. “I look forward to carefully considering these grant applications with my colleagues on the Scientific Advisory Board in order to maximize our impact in lymphoma research.”

LRF supports innovative research through Clinical Investigator Career Development Awards, Fellowships and several disease-specific research initiatives. For complete details regarding the Foundation’s current requests for proposals (RFPs), including a full list of focus areas and specifications, visit

About the Lymphoma Research Foundation
The Lymphoma Research Foundation (LRF) is the nation’s largest non-profit organization devoted to funding innovative research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and patient services. To date, LRF has awarded more than $51 million in lymphoma-specific research.

For additional information on LRF’s research, education and services, please visit

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Peggy Ann Torney
Follow us on
Visit website